RT Journal Article
T1 A bibliometric analysis of scientific production on second-generation anti-psychotic drugs in Malaysia.
A1 López Muñoz, Francisco
A1 Povedano Montero, Francisco Javier
A1 Chee, Kok-Yoon
A1 Shen, Winston W
A1 Fernández Martín, María Poveda
A1 Pacios García, Javier
A1 Rubio Valladolid, Gabriel
A1 Álamo, Cecilio
AB Objective: We carried out a bibliometric study on the scientific papers related to secondgeneration antipsychotic drugs (SGAs) in Malaysia. Methods: With the SCOPUS database, we selected those documents made in Malaysia whose title included descriptors related to SGAs. We applied bibliometric indicators of production and dispersion, as Price’s law and Bradford’s law, respectively. We also calculated the participation index of the different countries. The bibliometric data were also been correlated with some social and health data from Malaysia (total per capita expenditure on health and gross domestic expenditure on R&D). Results: We found 105 original documents published between 2004 and 2016. Our results fulfilled Price's law, with scientific production on SGAs showing exponential growth ( = 0.401, vs.  = 0.260 after linear adjustment). The drugs most studied are olanzapine (9 documents), clozapine (7), and risperidone (7). Division into Bradford zones yields a nucleus occupied by the . Totally, 63 different journals were used, but only one in the top four journals had an impact factor being greater than 3. Conclusion: The publications on SGAs in Malaysia have undergone exponential growth, without evidence a saturation point.
PB Penerbit Universiti Sains Malaysia
YR 2018
FD 2018-06-28
LK https://hdl.handle.net/20.500.14352/118913
UL https://hdl.handle.net/20.500.14352/118913
LA eng
NO López-Muñoz F, Povedano-Montero FJ, Chee KY, Shen WW, Fernández-Martín P, García-Pacios J, Rubio G, Álamo C. A Bibliometric Analysis of Scientific Production on Second-Generation Anti-Psychotic Drugs in Malaysia. Malays J Med Sci. 2018 May;25(3):40-55. doi: 10.21315/mjms2018.25.3.5.
DS Docta Complutense
RD 23 abr 2025